vaccine adverse event reporting system

(redirected from VAERS)
Also found in: Acronyms.

vaccine adverse event reporting system

,

VAERS

A national surveillance system for monitoring undesirable reactions to administered vaccines.
References in periodicals archive ?
Of these measles-vaccine related adverse event reports to VAERS, 329 were deaths, with over half of the deaths occurring in children under three years of age.
VAERS was also valuable in guiding decisions during the polio vaccination campaigns.
This report is a follow-up study to determine if the apparent medication errors in the VAERS database are true errors and if true errors are found, to determine what corrective action was taken locally to prevent or minimize the occurrence of a similar error in the future.
In order to examine the VAERS database appropriately, the meta-analysis study used the general epidemiological technique developed by researchers at the US CDC'S the National Immunization Program (NIP).
33) So why hasn't the FDA, the CDC, the American Academy of Pediatrics, or Merck itself responded to the VAERS reports that Gardasil is not a safe vaccine?
Vaccine safety: summary of adverse events in pregnant women following administration of TIV and LAIV in VAERS, 1990-2009 [Web document].
Most of the adverse event reports to VAERS were consistent with pre-licensure trial data.
Adverse events following vaccination with YF vaccine reported to VAERS were collected and categorized as systemic, nonsystemic, or unrelated and were classified by age group.
LIST OF EXHIBITS TWO: INTRODUCTION TO VACCINES Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2012 Figure 2-1: Attenuated Virus Production Table 2-2: Vaccine-Preventable Diseases, March 2014 Table 2-3: VAERS Table of Reportable Events Following Vaccination THREE: PEDIATRIC PREVENTIVE VACCINES Table 3-1: Total Number of Children Who Died from Diseases Preventable by Vaccines Recommended by the WHO 2012 Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990 - 2012 Table 3-3: Marketplace Enrollment as a Share of the Eligible Population,December 2013 Table 3-4: U.
Since licensed in October 2009, VAERS has received 3 adverse event reports occurring in the US following Cervarix.
In all 9,749 adverse events were reported to VAERS in association with administration of Gardasil, of which 94% were classified as nonserious events, and 6% as serious events.
Information regarding adverse events that are associated with Gardasil is available on the FDA's VAERS Web site (www.